Advertisement
Short Communication| Volume 45, ISSUE 7, P1107-1110, May 2009

Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma

  • Author Footnotes
    e Both Hai-Qiang Mai and Hao-Yuan Mo contributed equally to this manuscript.
    Hai-Qiang Mai
    Footnotes
    e Both Hai-Qiang Mai and Hao-Yuan Mo contributed equally to this manuscript.
    Affiliations
    State Key Laboratory of Oncology in Southern China and Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou 510060, China
    Search for articles by this author
  • Author Footnotes
    e Both Hai-Qiang Mai and Hao-Yuan Mo contributed equally to this manuscript.
    Hao-Yuan Mo
    Footnotes
    e Both Hai-Qiang Mai and Hao-Yuan Mo contributed equally to this manuscript.
    Affiliations
    State Key Laboratory of Oncology in Southern China and Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou 510060, China
    Search for articles by this author
  • Jing-Feng Deng
    Affiliations
    Department of Radiation Oncology, Tumour Hospital, Guangzhou Medical College, Guangzhou, China
    Search for articles by this author
  • Man-Quan Deng
    Correspondence
    Corresponding author: Tel.: +86 20 87343380; fax: +86 20 87343392.
    Affiliations
    State Key Laboratory of Oncology in Southern China and Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou 510060, China
    Search for articles by this author
  • Wei-Yuan Mai
    Affiliations
    Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX, USA
    Search for articles by this author
  • Xiao-Ming Huang
    Affiliations
    Department of Otolaryngology, The Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
    Search for articles by this author
  • Xiang Guo
    Affiliations
    State Key Laboratory of Oncology in Southern China and Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou 510060, China
    Search for articles by this author
  • Ming-Huang Hong
    Affiliations
    State Key Laboratory of Oncology in Southern China and Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou 510060, China
    Search for articles by this author
  • Author Footnotes
    e Both Hai-Qiang Mai and Hao-Yuan Mo contributed equally to this manuscript.
Published:March 27, 2009DOI:https://doi.org/10.1016/j.ejca.2009.02.028

      Abstract

      The result of reirradiation in recurrent T1 (rT1) nasopharyngeal carcinoma (NPC) is unsatisfactory. We sought to study the efficacy and complications of endoscopic microwave coagulation therapy (MCT) in salvaging rT1 NPC after primary radiotherapy. Between August 1994 and April 2005, 55 patients with rT1 NPC were treated with endoscopic MCT. With a median follow-up of 102.1 months, 52 of 55 patients are still alive. Five patients had local failure after retreatment. The overall survival and local progression-free survival were 100% (95% CI, 99.4% to 100%) and 94.5% (95% CI, 94.1% to 94.9%) at 2 years, respectively, and 93.6% (95% CI, 93.5% to 94.4%) and 90.7% (95% CI, 90.2% to 91.2%) at 5 years. The common complications of endoscopic MCT were mild postoperative pain and headache. Nasopharyngeal necrosis was transient in one patient and subsided in 1 month. Endoscopic MCT achieved significant survival and tumour control without severe complications in selective rT1 NPC.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Min H.Q.
        Nasopharyngeal carcinoma.
        in: Gun G.Y. Epidemiology. People’s Medical Press, Beijing1996: 280-285
        • Lee A.W.
        • Law S.C.
        • Foo W.
        • et al.
        Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence.
        Int J Radiat Oncol Biol Phys. 1993; 26: 773-782
        • Teo P.M.
        • Kwan W.H.
        • Chan A.T.
        • et al.
        How successful is high-dose (> or =60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?.
        Int J Radiat Oncol Biol Phys. 1998; 40: 897-913
        • Lee A.W.
        • Foo W.
        • Law S.C.
        • et al.
        Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.
        Int J Radiat Oncol Biol Phys. 1997; 38: 43-52
        • Chua D.T.
        • Sham J.S.
        • Kwong D.L.
        • et al.
        Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment.
        Int J Radiat Oncol Biol Phys. 1998; 41: 379-386
        • Seki T.
        • Wakabayashi M.
        • Nakagawa T.
        • et al.
        Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.
        Cancer. 1994; 74: 817-825
        • Sato M.
        • Watanabe Y.
        • Ueda S.
        • et al.
        Microwave coagulation therapy for hepatocellular carcinoma.
        Gastroenterology. 1996; 110: 1507-1514
      1. Greene F.L. Page D.L. Fleming I.D. American Joint Committee on Cancer Staging manual. 6th ed. Springer, Philadelphia2002
        • Huskisson E.C.
        Measurement of pain.
        J Rheumatol. 1982; 9: 768-769
        • Kaplan E.L.
        • Meier P.
        Nonparametric estimation from incomplete observations.
        J Am Stat Assoc. 1958; 53: 457-481
        • Kwong D.L.
        • Wei W.I.
        • Cheng A.C.
        • et al.
        Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
        Cancer. 2001; 91: 1105-1113
        • Lu T.X.
        • Mai W.Y.
        • Teh B.S.
        • et al.
        Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
        Int J Radiat Oncol Biol Phys. 2004; 58: 682-687
        • Chua D.T.
        • Sham J.S.
        • Leung L.H.
        • Au G.K.
        Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
        Radiother Oncol. 2005; 77: 290-294
        • Wei W.I.
        Salvage surgery for recurrent primary nasopharyngeal carcinoma.
        Crit Rev Oncol Hematol. 2000; 33: 91-98
        • King W.W.
        • Ku P.K.
        • Mok C.O.
        • Teo P.M.
        Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience.
        Head Neck. 2000; 22: 215-222
        • Hsu M.M.
        • Hong R.L.
        • Ting L.L.
        • et al.
        Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases.
        Arch Otolaryngol Head Neck Surg. 2001; 127: 798-802
        • Fee Jr., W.E.
        • Moir M.S.
        • Choi E.C.
        • Goffinet D.
        Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up.
        Arch Otolaryngol Head Neck Surg. 2002; 128: 280-284
        • Isles M.G.
        • McConkey C.
        • Mehanna H.M.
        A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.
        Clin Otolaryngol. 2008; 33: 210-222